US judge mulls jury guidance, witness dispute as US antitrust trial over Xyrem looms
Hikma Pharmaceuticals and class plaintiffs headed for an antitrust showdown in California federal court next month lobbied the judge overseeing their case today over the testimony of a key witness and...To view the full article, register now.
Already a subscriber? Click here to view full article